AEON Biopharma Q4 2025 Earnings Major EPS Miss and No Revenue Weigh on Investor Sentiment Corbus Pharmaceuticals Q1 2026 Earnings SmallerThanExpected Loss Amid Pipeline Progress Day One Biopharmaceuticals Q4 2025 Earnings EPS Miss Amid Continued RD Investment VTVT Q1 2026 Earnings Massive EPS Surprise Driven by a NonRecurring Gain Arrow Financial Q1 2026 Earnings EPS Beats Estimates by 176 ONL Q1 2026 Earnings Significant EPS Miss as Losses Widen